X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3326) 3326
Publication (354) 354
Newsletter (292) 292
Newspaper Article (72) 72
Book Review (28) 28
Book / eBook (16) 16
Magazine Article (10) 10
Book Chapter (5) 5
Conference Proceeding (3) 3
Data Set (2) 2
Dissertation (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2668) 2668
meningitis (2149) 2149
immunology (1502) 1502
index medicus (1465) 1465
vaccines (1380) 1380
male (1009) 1009
female (1006) 1006
infectious diseases (987) 987
child (912) 912
adolescent (877) 877
infant (872) 872
child, preschool (858) 858
neisseria meningitidis - immunology (796) 796
adult (789) 789
vaccination (749) 749
neisseria meningitidis (701) 701
meningitis, meningococcal - prevention & control (686) 686
meningitis, meningococcal - immunology (646) 646
disease (624) 624
meningococcal vaccines - immunology (598) 598
microbiology (586) 586
epidemiology (581) 581
immunization (579) 579
medicine, research & experimental (557) 557
children (550) 550
neisseria-meningitidis (545) 545
meningitis, meningococcal - epidemiology (482) 482
meningococcal disease (474) 474
research (427) 427
animals (426) 426
proteins (409) 409
medical research (401) 401
middle aged (400) 400
meningococcal vaccines - administration & dosage (378) 378
allergy and immunology (375) 375
antigens (369) 369
bacteria (367) 367
medicine (366) 366
immunogenicity (364) 364
infections (360) 360
meningitis, meningococcal - microbiology (349) 349
research article (336) 336
analysis (329) 329
meningococcal infections - prevention & control (326) 326
public health (319) 319
medicine, experimental (315) 315
vaccine (306) 306
young adult (306) 306
epidemics (298) 298
age (294) 294
mortality (292) 292
health aspects (287) 287
antibodies, bacterial - blood (276) 276
neisseria meningitidis - classification (274) 274
pediatrics (271) 271
prevention (271) 271
bacterial meningitis (261) 261
meningococcal infections - epidemiology (261) 261
infant, newborn (260) 260
serotyping (259) 259
meningococcal meningitis (254) 254
mice (254) 254
studies (248) 248
incidence (247) 247
aged (246) 246
neisseria meningitidis - isolation & purification (246) 246
antibodies (244) 244
conjugate vaccine (243) 243
multidisciplinary sciences (240) 240
neisseria meningitidis - genetics (238) 238
infants (231) 231
bacterial-meningitis (229) 229
science (225) 225
surveillance (223) 223
vaccines, conjugate - immunology (223) 223
meningococcal infections - immunology (214) 214
polysaccharides (212) 212
pneumonia (210) 210
antigens, bacterial - immunology (207) 207
meningococcal vaccines (204) 204
streptococcus infections (204) 204
laboratories (202) 202
polysaccharides, bacterial - immunology (193) 193
risk factors (193) 193
serogroup (191) 191
meningococcal infections - microbiology (180) 180
carriage (179) 179
neisseria meningitidis, serogroup b - immunology (179) 179
united-states (174) 174
meningococcal infections (173) 173
teenagers (170) 170
disease outbreaks (169) 169
diagnosis (168) 168
immune response (166) 166
safety (166) 166
bacterial infections (160) 160
africa (157) 157
streptococcus-pneumoniae (155) 155
immunity (151) 151
meningococcal vaccines - adverse effects (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3477) 3477
Russian (67) 67
French (58) 58
Spanish (37) 37
Chinese (21) 21
German (14) 14
Portuguese (11) 11
Dutch (10) 10
Italian (9) 9
Japanese (5) 5
Norwegian (5) 5
Czech (4) 4
Danish (3) 3
Finnish (3) 3
Polish (3) 3
Turkish (3) 3
Slovak (2) 2
Arabic (1) 1
Croatian (1) 1
Hungarian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Review of Vaccines, ISSN 1476-0584, 04/2017, Volume 16, Issue 4, pp. 313 - 328
Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed the global importance of meningococcal disease (MD) and its continually changing... 
meningococcal disease | MenW | serogroups | Neisseria meningitidis | outbreaks | surveillance | Global Meningococcal Initiative | Epidemiology | prevention | vaccination | SOUTH-AFRICA | CLONAL COMPLEX | SEROGROUP-B DISEASE | NEISSERIA-MENINGITIDIS | C CONJUGATE VACCINATION | IMMUNOLOGY | ADVISORY-COMMITTEE | CLINICAL PRESENTATION | AFRICAN MENINGITIS BELT | LATIN-AMERICA | IMMUNIZATION PRACTICES | Meningococcal Infections - immunology | Meningococcal Infections - epidemiology | Meningococcal Vaccines - therapeutic use | Global Health | Humans | Meningococcal Infections - prevention & control | Meningitis, Meningococcal - epidemiology | Meningitis, Meningococcal - immunology | Meningitis, Meningococcal - prevention & control | Incidence | Neisseria meningitidis - immunology | Vaccines, Conjugate - immunology | Neisseria meningitidis - classification | Vaccines, Conjugate - therapeutic use | Immunization Programs | Disease Outbreaks - prevention & control | Meningococcal Vaccines - immunology | Vaccines, Conjugate/immunology | Meningococcal Infections/prevention & control | Meningitis, Meningococcal/epidemiology | Meningococcal Infections/immunology | Vaccines, Conjugate/therapeutic use | Meningococcal Vaccines/therapeutic use | Life Sciences | Human health and pathology | Infectious diseases | Meningitis, Meningococcal/prevention & control | Meningococcal Infections/epidemiology | Santé publique et épidémiologie | Meningitis, Meningococcal/immunology | Neisseria meningitidis/immunology | Meningococcal Vaccines/immunology | Disease Outbreaks/prevention & control | Neisseria meningitidis/classification
Journal Article
Journal of Infection, ISSN 0163-4453, 2017, Volume 75, Issue 1, pp. 1 - 11
Summary The Global Meningococcal Initiative (GMI) has recently considered current issues in Middle Eastern and African countries, and produced two... 
Infectious Disease | Middle East | North Africa | Vaccination | Sub-Saharan Africa | Meningococcal disease | Global Meningococcal Initiative (GMI) | SOUTH-AFRICA | INFECTIOUS DISEASES | COST-EFFECTIVENESS | CARRIAGE | CONJUGATE VACCINE | SEROGROUP-C | TURKEY | NEISSERIA-MENINGITIDIS | PROSPECTIVE SURVEILLANCE | HIV | ENGLAND | Meningococcal Infections - epidemiology | Humans | Serogroup | Meningococcal Infections - prevention & control | Meningococcal Infections - microbiology | Meningococcal Vaccines - adverse effects | Neisseria meningitidis - isolation & purification | Meningitis, Meningococcal - epidemiology | Middle East - epidemiology | Neisseria meningitidis - immunology | Turkey - epidemiology | Disease Outbreaks | Immunization Programs | Africa, Northern - epidemiology | Africa South of the Sahara - epidemiology | Meningococcal Vaccines - administration & dosage | Meningitis | Arab countries | HIV (Viruses) | Africa South of the Sahara/epidemiology | Meningococcal Vaccines/administration & dosage | Meningococcal Infections/prevention & control | Africa, Northern/epidemiology | Meningitis, Meningococcal/epidemiology | Meningococcal Vaccines/adverse effects | Life Sciences | Human health and pathology | Infectious diseases | Neisseria meningitidis/isolation & purification | Meningococcal Infections/epidemiology | Turkey/epidemiology | Santé publique et épidémiologie | Neisseria meningitidis/immunology | Meningococcal Infections/microbiology | Middle East/epidemiology
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 32, Issue 1, pp. 124 - 130
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 48, pp. 6529 - 6536
Highlights • MD epidemiology and vaccination strategies in Latin America were reviewed. • Routine infant MCC vaccination program was implemented in Brazil in... 
Allergy and Immunology | Surveillance | Global Meningococcal Initiative | Epidemiology | Vaccination | Meningococcal disease | Serogroup W | MEDICINE, RESEARCH & EXPERIMENTAL | CARRIAGE | SAO-PAULO | IMMUNOLOGY | CHILE | SEROGROUP | BRAZIL | STUDENTS | PROGRAM | VACCINES | AGE | Latin America - epidemiology | Meningococcal Infections - epidemiology | Public Health | Global Health | Humans | Child, Preschool | Argentina - epidemiology | Infant | Male | Meningococcal Infections - prevention & control | Disease Outbreaks - statistics & numerical data | International Cooperation | Vaccination - statistics & numerical data | Disease Outbreaks - prevention & control | Female | Meningococcal Vaccines - immunology | Chile - epidemiology | Meningococcal Vaccines - administration & dosage | Brazil - epidemiology | Infant, Newborn | Meningitis | Bacterial infections | Immunization | Vaccines | Laboratories | Meningococcal Vaccines/administration & dosage | Meningococcal Infections/prevention & control | Chile/epidemiology | Argentina/epidemiology | Latin America/epidemiology | Life Sciences | Human health and pathology | Vaccination/statistics & numerical data | Infectious diseases | Brazil/epidemiology | Meningococcal Infections/epidemiology | Disease Outbreaks/statistics & numerical data | Santé publique et épidémiologie | Meningococcal Vaccines/immunology | Disease Outbreaks/prevention & control
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 11/2010, Volume 51, Issue 10, pp. 1127 - 1137
Background. In the absence of an efficacious broadly protective vaccine, serogroup B Neisseria meningitidis (MenB) is the leading cause of bacterial meningitis... 
Antigens | Immune response | Vaccination | Vaccine components | Antibodies | Experimentation | Neisseria meningitidis | ARTICLES AND COMMENTARIES | Dosage | Epidemiology | Blood | UNITED-STATES | INFECTIOUS DISEASES | NEW-ZEALAND | PROTECTION | NEISSERIA-MENINGITIDIS | COMPONENTS | ANTIBODY | MICROBIOLOGY | IMMUNOLOGY | MENINGITIDIS GROUP-B | IMMUNOGENICITY | BACTERICIDAL ACTIVITY | NADA | Adhesins, Bacterial - genetics | Humans | Antigens, Bacterial - immunology | Neisseria meningitidis, Serogroup B - immunology | Infant | Male | Neisseria meningitidis, Serogroup B - genetics | Vaccines, Synthetic - immunology | Meningococcal Vaccines - adverse effects | Meningitis, Meningococcal - immunology | Neisseria meningitidis, Serogroup B - chemistry | Vaccines, Synthetic - adverse effects | Drug-Related Side Effects and Adverse Reactions | Female | Immunization Schedule | Antibodies, Bacterial - blood | Bacterial Outer Membrane Proteins - genetics | Serum Bactericidal Antibody Assay | Bacterial Outer Membrane Proteins - immunology | United Kingdom | Meningitis, Meningococcal - prevention & control | Cell Membrane - immunology | Meningococcal Vaccines - immunology | Vaccines, Synthetic - administration & dosage | Adhesins, Bacterial - immunology | Meningococcal Vaccines - administration & dosage | Prevention | Infants (Newborn) | Bacterial meningitis | Research | Demographic aspects | Diseases
Journal Article